CN104740312A - Traditional Chinese medicine composition for treating chronic gastritis and its preparation method and detection method - Google Patents
Traditional Chinese medicine composition for treating chronic gastritis and its preparation method and detection method Download PDFInfo
- Publication number
- CN104740312A CN104740312A CN201310739244.7A CN201310739244A CN104740312A CN 104740312 A CN104740312 A CN 104740312A CN 201310739244 A CN201310739244 A CN 201310739244A CN 104740312 A CN104740312 A CN 104740312A
- Authority
- CN
- China
- Prior art keywords
- radix
- filtrate
- ethanol
- add
- employ
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating chronic gastritis and its preparation method and detection method. The traditional Chinese medicine composition comprises, by weight, 150 parts of pilose asiabell root, 100 parts of poria cocos, 100 parts of bighead atractylodes rhizome, 100 parts of white peony root, 100 parts of red sage root, 100 parts of radix paeoniae rubrathe, 100 parts of bletilla rhizome, 20 parts of rheum officinale, 60 parts of costus root, 100 parts of szechwan chinaberry fruit, 100 parts of dark plum and 10 parts of natural indigo. The traditional Chinese medicine composition and pharmaceutically common accessory materials are processed to form granules. The preparation method and detection method have the characteristics of simpleness, feasibility, scientificity and high specificity.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition and the preparation and determination methods method thereof that are used for the treatment of chronic gastritis, belong to pharmaceutical preparations technology field.
Background technology
Chronic gastritis is common clinical, and sickness rate is higher.Its clinical characters is that the course of disease is long, touching difficulty heals, and bring inconvenience to the live and work of patient, also can develop into gastric precancerous lesion even gastric cancer individually, threat to life is healthy.Clinical common patient has dyspepsia to show, and as acid regurgitation, heating installation, early full, loss of appetite, feels sick.Obvious anorexia can be there is and lose weight in chronic atrophic gastritis, and with anemia.Chronic gastritis refers to that multiple harmful factor damages repeatedly, causes the chronic inflammatory diseases of gastric mucosa.Think at present the generation of primary disease and acute gastritis, upper respiratory tract infection focus, to stimulate addicted to tobacco and wine, improper diet, bile reflux, achlorhydria, malnutrition, autoimmune response and chronic drug and Helicobacter pylori infects relevant.Regular epigastric distension and distress, stomachache, belch, acid regurgitation or inappetence etc. are main manifestations clinically.Chronic superficial gastritis, chronic atrophic gastritis and hypertrophic gastritis three class is divided into by histology.Superficial gastritis can change into atrophic gastritis or deposit with atrophic gastritis, and minority atrophic gastritis can develop into gastric cancer again.For chronic gastritis, most of Western medicine can only temporary relief of symptoms, and can not eradicate disease, long-term taking can produce certain dependency and Drug resistance, and side effect is larger.And the invention provides one treat chronic gastritis clinically application aspect have significant curative effect, and the Chinese medicine composition that toxic and side effects is less.
The traditional Chinese medical science thinks that chronic gastritis is with gastral cavilty portion pain recurrent exerbation for feature, and disease is longer is a kind of disease of feature, belongs to Chinese medicine " gastral cavilty is sick ", " stomach painful abdominal mass " category.With regard to the cause of disease, weakness of the spleen and stomach is its intrinsic factor, and eating and drinking without temperance, feelings will are hindered, work and rest excessive, inward invasion of pathogenic cold is its risk factor.Eating and drinking without temperance, stagnant does not change, and strongly fragrantly holds back mechanism of qi; Be worried angry, the liver failing to maintain the normal flow of QI, stagnation of QI gastral cavilty; Excessive hard work then wasting QI-blood, excessive idleness then mechanism of qi does not relax; Inward invasion of pathogenic cold, stagnate gastral cavilty, and emptiness of spleen and stomach, above factors cause functional activity of QI being not smooth in addition, stasis gastral cavilty, and abnormal ascending-descending of QI is the basic pathogenesis of primary disease.Primary disease produces and many to stagnate, caused by stagnation of QI due to depression of the liver, damp and hot interior Sheng, intemperance of taking food because of cold-evil.Have in treatment primary disease Zhang Zhongjing " banxia xiexin decoction " pungent drugs can disperse and bitter drugs can descend, cold and heat and adjust, the method for reinforcement and elimination in combination, specify that the thinking of the side's of sending medication for treating gastropathy later age.In Qing Dynasty Lee in " Zhengzi Huibu feeling of fullness " to " treatment of primary disease, just should Shu Yu, reduce phlegm, pathogenic fire reducing, should consolidate middle gas for a long time and help with his medicine; Have expectorant to control expectorant, have fire to relieve inflammation or internal heat, Yu Ze doubleization." traditional Chinese medicine composition for treating weakness of the spleen and stomach of the present invention, qi stagnation blood stasis chronic gastritis have definite curative effect.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine composition being used for the treatment of chronic gastritis, said composition has clear curative effect, quality controllable feature.
Another object of the present invention is to preparation method and the detection method thereof of protecting said composition.
Chinese medicine composition of the present invention is prepared from by following crude drug and method:
A: raw material and weight proportion composition: Radix Codonopsis 150, Poria 100, the Rhizoma Atractylodis Macrocephalae 100, the Radix Paeoniae Alba 100, Radix Salviae Miltiorrhizae 100, Radix Paeoniae Rubra 100, Pseudobulbus Bletillae (Rhizoma Bletillae) 100, Radix Et Rhizoma Rhei 20, the Radix Aucklandiae 60, Fructus Toosendan 100, Fructus Mume 100, Indigo Naturalis 10;
B: by 12 taste crude drug of above-mentioned weight proportion, operates according to the following steps:
(1) get Radix Codonopsis, Radix Salviae Miltiorrhizae, Radix Et Rhizoma Rhei, the Radix Aucklandiae, Fructus Toosendan, Pseudobulbus Bletillae (Rhizoma Bletillae), Fructus Mume medical material, add alcohol reflux, filter, alcohol filtrate is continued to employ;
(2) get Indigo Naturalis, Radix Paeoniae Rubra, the Rhizoma Atractylodis Macrocephalae, Poria, white Peony Root, add the water that pH value is 3.0 ~ 9.0, heating decocts extracts, and filter, add ethanol precipitate with ethanol in filtrate, ethanol is continued to employ;
By step (1), (2) in alcohol liquid merge, reclaim ethanol, dry be also ground into dried cream powder, to obtain final product.
Wherein, the method step preferably preparing the present composition is:
(1) get Radix Codonopsis, Radix Salviae Miltiorrhizae, Radix Et Rhizoma Rhei, the Radix Aucklandiae, Fructus Toosendan, Pseudobulbus Bletillae (Rhizoma Bletillae), Fructus Mume medical material, to add with medical material weight ratio be 6-10 times amount, concentration is the ethanol of 60%-80%, heating and refluxing extraction 2-3 time, each 1-3h, filters, and merges alcohol filtrate, continues to employ;
(2) get Indigo Naturalis, Radix Paeoniae Rubra, the Rhizoma Atractylodis Macrocephalae, Poria, white Peony Root, to add with medical material weight ratio be 6-12 times amount, pH value is the water of 3.0 ~ 9.0, heating decocts extraction 3 times, each 1-3h, filters, adds ethanol and make alcohol content reach 60%-80% in filtrate, leave standstill, centrifugalize, ethanol is continued to employ;
By step (1), (2) in alcohol liquid merge, reclaim ethanol, dry be also ground into dried cream powder, to obtain final product.
Further, the best approach step preparing the present composition is:
(1) get Radix Codonopsis, Radix Salviae Miltiorrhizae, Radix Et Rhizoma Rhei, the Radix Aucklandiae, Fructus Toosendan, Pseudobulbus Bletillae (Rhizoma Bletillae), Fructus Mume medical material, to add with medical material weight ratio be 8 times amount, concentration is the ethanol of 70%, heating and refluxing extraction 2 times, each 2h, filters, and merges alcohol filtrate, continues to employ;
(2) get Indigo Naturalis, Radix Paeoniae Rubra, the Rhizoma Atractylodis Macrocephalae, Poria, white Peony Root, to add with medical material weight ratio be 10 times amount, pH value is the water of 4.0, heating decocts extracts 1.5h, and filter, filtrate is continued to employ; To add in medicinal residues with medical material weight ratio be 8 times amount, pH value is the water of 6.5, and heating decocts extracts 1h, and filter, filtrate is continued to employ; To add in medicinal residues with medical material weight ratio be 8 times amount, pH value is the water of 8.5, and heating decocts extracts 1h, filters, and after the filtrate that filtrate and above-mentioned two places continue to employ merges, then adds ethanol and make alcohol content reach 70%, standing, centrifugalize, and ethanol is continued to employ;
By step (1), (2) in alcohol liquid merge, reclaim ethanol, dry be also ground into dried cream powder, to obtain final product.
The Chinese medicine composition invented in technique scheme, then add pharmaceutic adjuvant common in drug preparation technique and can be prepared into granule.
The Chinese medicine composition invented in technique scheme, its TLC Identification and result comprise one or more in following method:
(1) the discrimination method of Radix Et Rhizoma Rhei: get compositions 10g, adds chloroform 50ml, reflux 1 hour, and filter, filtrate is concentrated into 1ml, as need testing solution; Separately get Radix Et Rhizoma Rhei control medicinal material powder 0.2g, be made in the same way of control medicinal material solution; According to Chinese Pharmacopoeia 2010 editions one annex VI B thin layer chromatography test, draw above-mentioned two kinds of solution for 20 μ l, put respectively on same silica gel g thin-layer plate, with normal hexane-petroleum ether-ethyl acetate-methanol=3:1:1.5:0.1 for developing solvent, launch, take out, dry, inspect under the ultra-violet lamp of 365nm, in test sample chromatograph, on the position corresponding to control medicinal material chromatograph, the fluorescence speckle of aobvious same color;
(2) the discrimination method of Indigo Naturalis: get compositions 10g, adds chloroform 50ml, reflux 1 hour, and filter, filtrate is concentrated into 1ml, as need testing solution; Get indigo with indirubin reference substance, the mixed solution respectively containing 1mg in every 1ml copied into by chlorination, product solution in contrast; According to Chinese Pharmacopoeia 2010 editions one annex VI B thin layer chromatography test, draw above-mentioned two kinds of solution for 20 μ l, put respectively on same silica gel g thin-layer plate, with benzene-methanol=9:1 for developing solvent, launch, take out, dry; In test sample chromatograph, on the position corresponding to reference substance chromatograph, the speckle of aobvious same color;
(3) the discrimination method of Radix Paeoniae: get compositions 10g, adds ethyl acetate 20ml, reflux 1 hour, and filter, filtrate evaporate to dryness, residue adds methanol 1ml makes dissolving, as need testing solution; Separately get peoniflorin reference substance, add methanol and make the solution of every 1ml containing 1mg, product solution in contrast; According to Chinese Pharmacopoeia 2010 editions one annex VI B thin layer chromatography test, draw each 10 μ l of above-mentioned two kinds of solution, put respectively on same silica gel g thin-layer plate, with chloroform-ethyl acetate-methyl alcohol-formic acid=40:5:10:0.2 for developing solvent, launch, take out, dry, spray is with 5% vanillin-sulfuric acid solution, and it is clear that hot blast blows to spot development; In test sample chromatograph, on the position corresponding to reference substance chromatograph, aobvious identical bluish violet speckle.
Chinese medicine composition of the present invention, in prescription, Radix Codonopsis has spleen reinforcing stomach reinforcing effect, Radix Salviae Miltiorrhizae promoting blood circulation and cooling blood, and granulation promoting is put on flesh, two medicine compatibilities, benefiting QI for activating blood circulation pain relieving, is monarch drug altogether.Rhizoma Atractylodis Macrocephalae replenishing QI to invigorate the spleen dampness, to help Radix Codonopsis; Radix Aucklandiae promoting the circulation of QI to relieve pain, compatible with Radix Salviae Miltiorrhizae, gas one blood, adjusts smooth QI and blood; Radix Paeoniae Alba relieving spasm to stop pain; Radix Et Rhizoma Rhei heat clearing and blood circulation promoting.To help Radix Salviae Miltiorrhizae, above-mentioned four tastes assist monarch drug air making-up and spleen enlivening, heat clearing and blood circulation promoting, and promoting the circulation of QI to relieve pain are monarch drug altogether.Poria spleen invigorating eliminating dampness by diuresis coordinates Radix Salviae Miltiorrhizae, Radix Et Rhizoma Rhei removing heat from blood and promoting blood circulation, Fructus Toosendan promoting the circulation of QI to relieve pain to help the Rhizoma Atractylodis Macrocephalae, Indigo Naturalis, Radix Paeoniae Rubra, and Pseudobulbus Bletillae (Rhizoma Bletillae) helps Radix Salviae Miltiorrhizae detumescence and promoting granulation; Fructus Mume reinforcing stomach reg fluid, in case the product damage stomach-Yin that all hardships are dry, above-mentioned Six-element is adjuvant drug altogether.All medicines match, reinforcing and reducing use, and QI and blood is also controlled, giving consideration to both the incidental and fundamental, righting and do not love heresy, and get rid of evils and just do not hinder, temper must be good for, QI and blood is unobstructed, and pathogenic heat must be fallen, and abdominal distention, weak, all cards of bitter taste, halitosis can be healed.
The present invention is in the middle of practical study process, the research of novelty has been carried out to the preparation method of compositions, define alcohol extraction, the Reasonable Parameters scope of the technical schemes such as semi-bionic extraction, we set forth comparatively clearly to it respectively below, to highlight the beneficial effect of technical solution of the present invention accordingly.Meanwhile, we also conduct in-depth research the quality determining method of the present composition, finally define the thin-layer identification method of the present composition, and the technical scheme of above invention will be applied for this medicine and provide solid guarantee.
(1) semi-bionic extraction:
In the research process of present composition preparation method, we carry out the exploration of alcohol extraction, percolation, dipping, water extraction etc. general extraction methods respectively to different flavour of a drug, accidentally creationary explored by Indigo Naturalis, Radix Paeoniae Rubra, the Rhizoma Atractylodis Macrocephalae, Poria, the Radix Paeoniae Alba etc. 5 taste medical material mixing after, take the technical scheme that semi-biomimetic method extracts, this is non-obvious for a person skilled in the art.In addition, semi-biomimetic method is the emerging extract drugs technology of Modern Pharmaceutics, its have meet medicine through gastrointestinal transit process, be applicable to suitability for industrialized production, embody the traditional Chinese medical science and to cure the disease the feature of comprehensive composition effect, be not equal to " acid-base method " of pure chemistry viewpoint.The technology point of the method core is the most to extract the medicine " active mixture " that applicable human intestines and stomach absorbs, and this entirety with Chinese medicine, the guiding theory unifying to play curative effect match.
(2) ethanol extraction:
For Chinese medicine composition of the present invention, in research, we pursue refine, effective extracting mode, through a large amount of screenings, comparison, after only alcohol extraction being carried out to 7 taste medical materials such as Radix Codonopsis, Radix Salviae Miltiorrhizae, Radix Et Rhizoma Rhei, the Radix Aucklandiae, Fructus Toosendan, Pseudobulbus Bletillae (Rhizoma Bletillae), Fructus Mumes, after extracting solution is coordinated with the medicinal liquid obtained by other processing step, just can reach therapeutic effect significantly, that is can solve the present invention for the technical problem of disease, and good technique effect can be obtained; Therefore, we have reason to believe, after independent alcohol extraction being carried out to above crude drug in the present invention, can not only cost-saving, simplify preparation process, thus reduce industrialization working strength, meanwhile, good therapeutic effect can also be reached.
(3) quality determining method:
We are for compositions of the present invention, establish the thin-layered chromatography detection method that science, specificity are good, the stability guaranteeing the quality of compositions that it can be strong and effectiveness.
Be below that pharmacodynamic study test is carried out to the medicine that technical solution of the present invention obtains, because core innovative point of the present invention is the extraction and preparation technique aspect of medical material, illustrate the pharmacodynamics curative effect of Drug therapy chronic gastritis of the present invention fully.In conjunction with the research level of modern pharmacology, study medicine of the present invention to rat model gastric juice free acidity, pepsic activity, and the experiment such as gastrin changes of contents in rat blood serum, in order to simplify experimental implementation, save research expenditure, follow the experiment principle of parallel control, get rid of the Different therapeutical effect that each medicine group is brought because of Dosage Form Factors itself, below preferably Parameter Conditions is selected in technical solution of the present invention in test, but this can derive for those skilled in the art completely thus, understand the beneficial effect of other parameter point technical scheme in the application, therefore the technology of the present invention content and pharmacodynamic results are certainly not limited thereto scope.
1 test material and method:
The preparation of 1.1 trial drugs:
The preparation of product group in the middle of medicine of the present invention:
(1) get Radix Codonopsis 150g, Radix Salviae Miltiorrhizae 100g, Radix Et Rhizoma Rhei 20g, Radix Aucklandiae 60g, Fructus Toosendan 100g, Pseudobulbus Bletillae (Rhizoma Bletillae) 100g, Fructus Mume 100g medical material, to add with medical material weight ratio be 8 times amount, concentration is the ethanol of 70%, heating and refluxing extraction 2 times, each 2h, filter, merge alcohol filtrate, continue to employ;
(2) get Indigo Naturalis 10g, Radix Paeoniae Rubra 100g, Rhizoma Atractylodis Macrocephalae 100g, Poria 100g, Radix Paeoniae Alba 100g medical material, to add with medical material weight ratio be 10 times amount, pH value is the water of 4.0, heating decocts extracts 1.5h, and filter, filtrate is continued to employ; To add in medicinal residues with medical material weight ratio be 8 times amount, pH value is the water of 6.5, and heating decocts extracts 1h, and filter, filtrate is continued to employ; To add in medicinal residues with medical material weight ratio be 8 times amount, pH value is the water of 8.5, and heating decocts extracts 1h, filters, and after the filtrate that filtrate and above-mentioned two places continue to employ merges, then adds ethanol and make alcohol content reach 70%, standing, centrifugalize, and ethanol is continued to employ;
By step (1), (2) in alcohol liquid merge, reclaim ethanol, dry be also ground into dried cream powder, mixing, obtain Traditional Chinese drug mixture, before use, adding distil water is mixed with suspendible medicinal liquid, to obtain final product.
1.2 experimental animals: Wistar rat, male and female dual-purpose body weight is 180 ~ 220g, purchased from The Fourth Military Medical University's Experimental Animal Center.
1.3 statistical procedures: experimental result with
represent, adopt t inspection, measure the significance of group difference.
2. the test of pesticide effectiveness and result:
Get rat 45, male and female half and half, be divided into the 1st at random, 2, 3 groups, be respectively Normal group, model group, product group in the middle of medicine of the present invention, often organize 15, except the rat of Normal group gives normal saline, all the other are respectively organized rat and carry out modeling, namely within 1st month, only gavage 60% ethanol 2ml/ every 10d at every turn, and 20mmol/L deoxycholic acid sodium solution is arbitrarily drunk as beverage, the 2nd, 3 months every 7d respectively to drinking 30% ethanol and 10mmol/L deoxycholic acid sodium solution, before modeling terminates, extract minority animal and do pathology of gastric mucosa histological examination, after confirming the success of chronic gastritis model, get the rat after modeling success, often organize random selecting 10, every day gastric infusion 1 time, continuous 42d, each treated animal is fasting 12h after last administration, put to death, get blood 4ml respectively and be placed in test tube, and with 3000r/min, centrifugal 5min, separation of serum is preserved at-20 DEG C, adopt radioimmunology, measure the content of gastrin, in addition, win full stomach respectively for each group, along greater gastric curvature, portion cuts gastral cavity open, with 6mL distilled water flushing gastral cavity, after liquid to be cleaned is centrifugal, gets supernatant, by titration measuring gastric juice free acidity, measures pepsin activity, the results are shown in Table 1 by wheat Te Shi method.
Table 1 is on the impact of chronic gastritis rat digestive function
Note: compare after treating with normal group,
■ ■p<0.01; Compare after treating with model group,
* *p<0.001,
*p<0.01,
*p<0.05.
Result of the test from table 1 is known: compare with Normal group, in model group rats gastric juice Free Acid degree, pepsin and serum, gastrin content all has significant diversity (P < 0.01), and this shows that the modeling method adopted in this test is successful fully; Compare with model group, in the middle of medicine of the present invention, product group improves the pepsin activity (P < 0.001) of rat extremely significantly, gastrin content in its blood finally recorded increases to some extent, reach the significance difference opposite sex (P<0.01) on statistical significance, in addition, obvious lifting (P<0.01) be there has also been for gastric juice Free Acid angle value.In a word, in the middle of medicine of the present invention, product group has rising test rat gastric juice Free Acid degree, strengthens pepsic activity, and the effect such as gastrin content in increase rat blood serum, these effects are pharmacological basis for the treatment of chronic gastritis disease, and therefore this test discloses: medicine of the present invention has the pharmacological action of outstanding treatment chronic gastritis.
Detailed description of the invention
Below the specific embodiment of content of the present invention, for set forth in present specification want the technical scheme of technical solution problem, contributes to those skilled in the art and understand content of the present invention, but the realization of technical solution of the present invention is not limited to these embodiments.
Embodiment 1
(1) get Radix Codonopsis 150g, Radix Salviae Miltiorrhizae 100g, Radix Et Rhizoma Rhei 20g, Radix Aucklandiae 60g, Fructus Toosendan 100g, Pseudobulbus Bletillae (Rhizoma Bletillae) 100g, Fructus Mume 100g medical material, to add with medical material weight ratio be 8 times amount, concentration is the ethanol of 70%, heating and refluxing extraction 2 times, each 2h, filter, merge alcohol filtrate, continue to employ;
(2) get Indigo Naturalis 10g, Radix Paeoniae Rubra 100g, Rhizoma Atractylodis Macrocephalae 100g, Poria 100g, Radix Paeoniae Alba 100g medical material, to add with medical material weight ratio be 10 times amount, pH value is the water of 4.0, heating decocts extracts 1.5h, and filter, filtrate is continued to employ; To add in medicinal residues with medical material weight ratio be 8 times amount, pH value is the water of 6.5, and heating decocts extracts 1h, and filter, filtrate is continued to employ; To add in medicinal residues with medical material weight ratio be 8 times amount, pH value is the water of 8.5, and heating decocts extracts 1h, filters, and after the filtrate that filtrate and above-mentioned two places continue to employ merges, then adds ethanol and make alcohol content reach 70%, standing, centrifugalize, and ethanol is continued to employ;
By step (1), (2) in alcohol liquid merge, reclaim ethanol, dry be also ground into dried cream powder, granulate, obtain 1000g granule.
Embodiment 2
(1) get Radix Codonopsis 150g, Radix Salviae Miltiorrhizae 100g, Radix Et Rhizoma Rhei 20g, Radix Aucklandiae 60g, Fructus Toosendan 100g, Pseudobulbus Bletillae (Rhizoma Bletillae) 100g, Fructus Mume 100g medical material, to add with medical material weight ratio be 6 times amount, concentration is the ethanol of 80%, heating and refluxing extraction 3 times, each 1h, filter, merge alcohol filtrate, continue to employ;
(2) get Indigo Naturalis 10g, Radix Paeoniae Rubra 100g, Rhizoma Atractylodis Macrocephalae 100g, Poria 100g, Radix Paeoniae Alba 100g medical material, to add with medical material weight ratio be 12 times amount, pH value is the water of 3.0, heating decocts extracts 2h, and filter, filtrate is continued to employ; To add in medicinal residues with medical material weight ratio be 10 times amount, pH value is the water of 5.5, and heating decocts extracts 1h, and filter, filtrate is continued to employ; To add in medicinal residues with medical material weight ratio be 6 times amount, pH value is the water of 9.0, and heating decocts extracts 1h, filters, and after the filtrate that filtrate and above-mentioned two places continue to employ merges, then adds ethanol and make alcohol content reach 60%, standing, centrifugalize, and ethanol is continued to employ;
By step (1), (2) in alcohol liquid merge, reclaim ethanol, dry be also ground into dried cream powder, granulate, obtain 1000g granule.
Embodiment 3
(1) get Radix Codonopsis 150g, Radix Salviae Miltiorrhizae 100g, Radix Et Rhizoma Rhei 20g, Radix Aucklandiae 60g, Fructus Toosendan 100g, Pseudobulbus Bletillae (Rhizoma Bletillae) 100g, Fructus Mume 100g medical material, to add with medical material weight ratio be 10 times amount, concentration is the ethanol of 60%, heating and refluxing extraction 2 times, each 3h, filter, merge alcohol filtrate, continue to employ;
(2) get Indigo Naturalis 10g, Radix Paeoniae Rubra 100g, Rhizoma Atractylodis Macrocephalae 100g, Poria 100g, Radix Paeoniae Alba 100g medical material, to add with medical material weight ratio be 10 times amount, pH value is the water of 4.0, heating decocts extracts 3h, and filter, filtrate is continued to employ; To add in medicinal residues with medical material weight ratio be 10 times amount, pH value is the water of 7.5, and heating decocts extracts 2h, and filter, filtrate is continued to employ; To add in medicinal residues with medical material weight ratio be 6 times amount, pH value is the water of 9.0, and heating decocts extracts 1h, filters, and after the filtrate that filtrate and above-mentioned two places continue to employ merges, then adds ethanol and make alcohol content reach 80%, standing, centrifugalize, and ethanol is continued to employ;
By step (1), (2) in alcohol liquid merge, reclaim ethanol, dry be also ground into dried cream powder, granulate, obtain 1000g granule.
For medicine obtained in above embodiment, indentification by TLC can be carried out by following method, carry out the quality of detection and control medicine of the present invention with this.
(1) the discrimination method of Radix Et Rhizoma Rhei: get obtained medicine 10g, add chloroform 50ml, reflux 1 hour, filter, filtrate is concentrated into 1ml, as need testing solution; Separately get Radix Et Rhizoma Rhei control medicinal material powder 0.2g, be made in the same way of control medicinal material solution; According to Chinese Pharmacopoeia 2010 editions one annex VI B thin layer chromatography test, draw above-mentioned two kinds of solution for 20 μ l, put respectively on same silica gel g thin-layer plate, with normal hexane-petroleum ether-ethyl acetate-methanol=3:1:1.5:0.1 for developing solvent, launch, take out, dry, inspect under the ultra-violet lamp of 365nm, in test sample chromatograph, on the position corresponding to control medicinal material chromatograph, the fluorescence speckle of aobvious same color;
(2) the discrimination method of Indigo Naturalis: get obtained medicine 10g, add chloroform 50ml, reflux 1 hour, filter, filtrate is concentrated into 1ml, as need testing solution; Get indigo with indirubin reference substance, the mixed solution respectively containing 1mg in every 1ml copied into by chlorination, product solution in contrast; According to Chinese Pharmacopoeia 2010 editions one annex VI B thin layer chromatography test, draw above-mentioned two kinds of solution for 20 μ l, put respectively on same silica gel g thin-layer plate, with benzene-methanol=9:1 for developing solvent, launch, take out, dry; In test sample chromatograph, on the position corresponding to reference substance chromatograph, the speckle of aobvious same color;
(3) the discrimination method of Radix Paeoniae: get obtained medicine 10g, add ethyl acetate 20ml, reflux 1 hour, filter, filtrate evaporate to dryness, residue adds methanol 1ml makes dissolving, as need testing solution; Separately get peoniflorin reference substance, add methanol and make the solution of every 1ml containing 1mg, product solution in contrast; According to Chinese Pharmacopoeia 2010 editions one annex VI B thin layer chromatography test, draw each 10 μ l of above-mentioned two kinds of solution, put respectively on same silica gel g thin-layer plate, with chloroform-ethyl acetate-methyl alcohol-formic acid=40:5:10:0.2 for developing solvent, launch, take out, dry, spray is with 5% vanillin-sulfuric acid solution, and it is clear that hot blast blows to spot development; In test sample chromatograph, on the position corresponding to reference substance chromatograph, aobvious identical bluish violet speckle.
In order to verify the curative effect of finished product preparation of the present invention further, the finished particle agent prepared in above-mentioned specific embodiment 1-3, capsule have been carried out corresponding clinical trial by us, existing that report the test is as follows.
Clinical observation and curative effect
1. physical data:
Collect in February, 2009 ~ in August, 2010 in tested case 114 example of the court patient, as object of study, wherein male 70 example, women 44 example; Age is 22 ~ 57 years old, year mean age (45.63 ± 2.58); The course of disease 6 months ~ 2.5 years; Be divided into 4 groups at random, wherein embodiment 1 group of 28 example, embodiment 2 group of 27 example, embodiment 3 group of 30 example, matched group (Weiwanshu granule medicament group) 29 example, all patients are according to age, sex, the course of disease, clinical symptoms etc., each group of there are no significant in physical data difference, has comparability.
Diagnostic criteria: with reference to " traditional Chinese medical science disease diagnosis and treatment standard and select with prescription " and " common disease diagnosis basis and Outcome measure are diagnosed ": gastroscopy finds gastric mucosa congestion edema, ulcer surface and petechia, rotten to the corn point.Gastric mucosa and gastric juice urease fast diagnose test paper method test helicobacter pylori (HP) are positive.The digestive symptoms etc. such as have gastral cavilty portion distending pain, burning sensation, repeatedly acid regurgitation, have the hiccups, meets above-mentioned condition, can be diagnosed as chronic gastritis and make a definite diagnosis.
2. Therapeutic Method
The oral embodiment of the present invention for the treatment of group 1 group, 2 groups, 3 groups medicines, each serving with 10g, every day 2 times; The oral Weiwanshu granule of matched group, every day 2 times, each 1 bag, was all a course for the treatment of with 4 weeks, takes 3 courses for the treatment of continuously.Treatments period, all coordinates the conditionings such as certain diet, psychology and work and rest custom.
3. therapeutic evaluation
Effective: after treatment, helicobacter pylori checks negative, and clinical symptoms and sign recover normal, fibergastroscopy gastric mucosa foci disappearance.Effective: after treatment, helicobacter pylori checks negative, and clinical symptoms and sign are improved in varying degrees, and fibergastroscopy gastric mucosa focus has and takes a turn for the better in various degree.Invalid: after treatment, helicobacter pylori checks positive, and clinical symptoms, sign stomach function regulating mucosa focus is unchanged or increase the weight of.
3.1 result of the tests (referring to table 2)
Table 2 is group clinical effectiveness statistics respectively
Result of the test from table 2: after the Drug therapy of 3 courses for the treatment of, its most of Patients with Chronic Gastritis, the acid regurgitation occurred, belch, loss of appetite, feel sick, abdominal part distending pain, the symptom such as to have the hiccups all improve significantly, and helicobacter pylori inspection is negative, gastric mucosa focus has and takes a turn for the better in various degree.The embodiment of the present invention 1 group, 2 groups, 3 groups total effective rates are respectively 85.7%, 81.5%, 76.6%, wherein, the curative effect that the embodiment of the present invention is 1 group is best, and the effective percentage of matched group Weiwanshu granule medicament group is only 58.6%, result shows, the clinical efficacy of Chinese medicine preparation in treatment gastritis disease prepared by technical solution of the present invention is remarkable, and is better than Weiwanshu granule medicament group, and over the course for the treatment of, do not find the untoward reaction of each embodiment group medicine.
Result shows, Chinese medicine preparation of the present invention has the advantages such as preparation technology's simple possible, stable curative effect be reliable, it is efficient, simplify, the medicinal material extract technique of science, effectively ensure that the action effect of the treatment chronic gastritis that Chinese medicine composition of the present invention is excellent, fully ensure that the market potential that said composition is huge, be worth further genralrlization.
Claims (9)
1. one kind is used for the treatment of the Chinese medicine composition of chronic gastritis, be made up of the medical material of following weight proportion: Radix Codonopsis 150, Poria 100, the Rhizoma Atractylodis Macrocephalae 100, the Radix Paeoniae Alba 100, Radix Salviae Miltiorrhizae 100, Radix Paeoniae Rubra 100, Pseudobulbus Bletillae (Rhizoma Bletillae) 100, Radix Et Rhizoma Rhei 20, the Radix Aucklandiae 60, Fructus Toosendan 100, Fructus Mume 100, Indigo Naturalis 10, it is characterized in that said composition is prepared from according to the following steps:
(1) get Radix Codonopsis, Radix Salviae Miltiorrhizae, Radix Et Rhizoma Rhei, the Radix Aucklandiae, Fructus Toosendan, Pseudobulbus Bletillae (Rhizoma Bletillae), Fructus Mume medical material, add alcohol reflux, filter, alcohol filtrate is continued to employ;
(2) get Indigo Naturalis, Radix Paeoniae Rubra, the Rhizoma Atractylodis Macrocephalae, Poria, white Peony Root, add the water that pH value is 3.0 ~ 9.0, heating decocts extracts, and filter, add ethanol precipitate with ethanol in filtrate, ethanol is continued to employ;
By step (1), (2) in alcohol liquid merge, reclaim ethanol, dry be also ground into dried cream powder, to obtain final product.
2. Chinese medicine composition as claimed in claim 1, is characterized in that it is prepared from by following steps:
(1) get Radix Codonopsis, Radix Salviae Miltiorrhizae, Radix Et Rhizoma Rhei, the Radix Aucklandiae, Fructus Toosendan, Pseudobulbus Bletillae (Rhizoma Bletillae), Fructus Mume medical material, to add with medical material weight ratio be 6-10 times amount, concentration is the ethanol of 60%-80%, heating and refluxing extraction 2-3 time, each 1-3h, filters, and merges alcohol filtrate, continues to employ;
(2) get Indigo Naturalis, Radix Paeoniae Rubra, the Rhizoma Atractylodis Macrocephalae, Poria, white Peony Root, to add with medical material weight ratio be 6-12 times amount, pH value is the water of 3.0 ~ 9.0, heating decocts extraction 3 times, each 1-3h, filters, adds ethanol and make alcohol content reach 60%-80% in filtrate, leave standstill, centrifugalize, ethanol is continued to employ;
By step (1), (2) in alcohol liquid merge, reclaim ethanol, dry be also ground into dried cream powder, to obtain final product.
3. Chinese medicine composition as claimed in claim 2, is characterized in that it is prepared from by following steps:
(1) get Radix Codonopsis, Radix Salviae Miltiorrhizae, Radix Et Rhizoma Rhei, the Radix Aucklandiae, Fructus Toosendan, Pseudobulbus Bletillae (Rhizoma Bletillae), Fructus Mume medical material, to add with medical material weight ratio be 8 times amount, concentration is the ethanol of 70%, heating and refluxing extraction 2 times, each 2h, filters, and merges alcohol filtrate, continues to employ;
(2) get Indigo Naturalis, Radix Paeoniae Rubra, the Rhizoma Atractylodis Macrocephalae, Poria, white Peony Root, to add with medical material weight ratio be 10 times amount, pH value is the water of 4.0, heating decocts extracts 1.5h, and filter, filtrate is continued to employ; To add in medicinal residues with medical material weight ratio be 8 times amount, pH value is the water of 6.5, and heating decocts extracts 1h, and filter, filtrate is continued to employ; To add in medicinal residues with medical material weight ratio be 8 times amount, pH value is the water of 8.5, and heating decocts extracts 1h, filters, and after the filtrate that filtrate and above-mentioned two places continue to employ merges, then adds ethanol and make alcohol content reach 70%, standing, centrifugalize, and ethanol is continued to employ;
By step (1), (2) in alcohol liquid merge, reclaim ethanol, dry be also ground into dried cream powder, to obtain final product.
4. the Chinese medicine composition as described in as arbitrary in claim 1-3, is characterized in that: add adjuvant conventional on pharmaceutics and make granule.
5. the Chinese medicine composition as described in as arbitrary in claim 1-3, is characterized in that: the thin-layer identification method of said composition comprises the combination of one or more in following methods:
(1) the discrimination method of Radix Et Rhizoma Rhei: get compositions 10g, adds chloroform 50ml, reflux 1 hour, and filter, filtrate is concentrated into 1ml, as need testing solution; Separately get Radix Et Rhizoma Rhei control medicinal material powder 0.2g, be made in the same way of control medicinal material solution; According to Chinese Pharmacopoeia 2010 editions one annex VI B thin layer chromatography test, draw above-mentioned two kinds of solution for 20 μ l, put respectively on same silica gel g thin-layer plate, with normal hexane-petroleum ether-ethyl acetate-methanol=3:1:1.5:0.1 for developing solvent, launch, take out, dry, inspect under the ultra-violet lamp of 365nm, in test sample chromatograph, on the position corresponding to control medicinal material chromatograph, the fluorescence speckle of aobvious same color;
(2) the discrimination method of Indigo Naturalis: get compositions 10g, adds chloroform 50ml, reflux 1 hour, and filter, filtrate is concentrated into 1ml, as need testing solution; Get indigo with indirubin reference substance, the mixed solution respectively containing 1mg in every 1ml copied into by chlorination, product solution in contrast; According to Chinese Pharmacopoeia 2010 editions one annex VI B thin layer chromatography test, draw above-mentioned two kinds of solution for 20 μ l, put respectively on same silica gel g thin-layer plate, with benzene-methanol=9:1 for developing solvent, launch, take out, dry; In test sample chromatograph, on the position corresponding to reference substance chromatograph, the speckle of aobvious same color;
(3) the discrimination method of Radix Paeoniae: get compositions 10g, adds ethyl acetate 20ml, reflux 1 hour, and filter, filtrate evaporate to dryness, residue adds methanol 1ml makes dissolving, as need testing solution; Separately get peoniflorin reference substance, add methanol and make the solution of every 1ml containing 1mg, product solution in contrast; According to Chinese Pharmacopoeia 2010 editions one annex VI B thin layer chromatography test, draw each 10 μ l of above-mentioned two kinds of solution, put respectively on same silica gel g thin-layer plate, with chloroform-ethyl acetate-methyl alcohol-formic acid=40:5:10:0.2 for developing solvent, launch, take out, dry, spray is with 5% vanillin-sulfuric acid solution, and it is clear that hot blast blows to spot development; In test sample chromatograph, on the position corresponding to reference substance chromatograph, aobvious identical bluish violet speckle.
6. prepare the method for Chinese medicine composition as claimed in claim 1, it is characterized in that:
A: raw material and weight proportion composition: Radix Codonopsis 150, Poria 100, the Rhizoma Atractylodis Macrocephalae 100, the Radix Paeoniae Alba 100, Radix Salviae Miltiorrhizae 100, Radix Paeoniae Rubra 100, Pseudobulbus Bletillae (Rhizoma Bletillae) 100, Radix Et Rhizoma Rhei 20, the Radix Aucklandiae 60, Fructus Toosendan 100, Fructus Mume 100, Indigo Naturalis 10;
B: by 12 taste crude drug of above-mentioned weight proportion, operates according to the following steps:
(1) get Radix Codonopsis, Radix Salviae Miltiorrhizae, Radix Et Rhizoma Rhei, the Radix Aucklandiae, Fructus Toosendan, Pseudobulbus Bletillae (Rhizoma Bletillae), Fructus Mume medical material, add alcohol reflux, filter, alcohol filtrate is continued to employ;
(2) get Indigo Naturalis, Radix Paeoniae Rubra, the Rhizoma Atractylodis Macrocephalae, Poria, white Peony Root, add the water that pH value is 3.0 ~ 9.0, heating decocts extracts, and filter, add ethanol precipitate with ethanol in filtrate, ethanol is continued to employ;
By step (1), (2) in alcohol liquid merge, reclaim ethanol, dry be also ground into dried cream powder, to obtain final product.
7. the preparation method of Chinese medicine composition as claimed in claim 6, is characterized in that:
(1) get Radix Codonopsis, Radix Salviae Miltiorrhizae, Radix Et Rhizoma Rhei, the Radix Aucklandiae, Fructus Toosendan, Pseudobulbus Bletillae (Rhizoma Bletillae), Fructus Mume medical material, to add with medical material weight ratio be 6-10 times amount, concentration is the ethanol of 60%-80%, heating and refluxing extraction 2-3 time, each 1-3h, filters, and merges alcohol filtrate, continues to employ;
(2) get Indigo Naturalis, Radix Paeoniae Rubra, the Rhizoma Atractylodis Macrocephalae, Poria, white Peony Root, to add with medical material weight ratio be 6-12 times amount, pH value is the water of 3.0 ~ 9.0, heating decocts extraction 3 times, each 1-3h, filters, adds ethanol and make alcohol content reach 60%-80% in filtrate, leave standstill, centrifugalize, ethanol is continued to employ;
By step (1), (2) in alcohol liquid merge, reclaim ethanol, dry be also ground into dried cream powder, to obtain final product.
8. the preparation method of Chinese medicine composition as claimed in claim 7, is characterized in that:
(1) get Radix Codonopsis, Radix Salviae Miltiorrhizae, Radix Et Rhizoma Rhei, the Radix Aucklandiae, Fructus Toosendan, Pseudobulbus Bletillae (Rhizoma Bletillae), Fructus Mume medical material, to add with medical material weight ratio be 8 times amount, concentration is the ethanol of 70%, heating and refluxing extraction 2 times, each 2h, filters, and merges alcohol filtrate, continues to employ;
(2) get Indigo Naturalis, Radix Paeoniae Rubra, the Rhizoma Atractylodis Macrocephalae, Poria, white Peony Root, to add with medical material weight ratio be 10 times amount, pH value is the water of 4.0, heating decocts extracts 1.5h, and filter, filtrate is continued to employ; To add in medicinal residues with medical material weight ratio be 8 times amount, pH value is the water of 6.5, and heating decocts extracts 1h, and filter, filtrate is continued to employ; To add in medicinal residues with medical material weight ratio be 8 times amount, pH value is the water of 8.5, and heating decocts extracts 1h, filters, and after the filtrate that filtrate and above-mentioned two places continue to employ merges, then adds ethanol and make alcohol content reach 70%, standing, centrifugalize, and ethanol is continued to employ;
By step (1), (2) in alcohol liquid merge, reclaim ethanol, dry be also ground into dried cream powder, to obtain final product.
9. the preparation method as described in as arbitrary in claim 6-8, is characterized in that: add adjuvant conventional on pharmaceutics and finally make granule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310739244.7A CN104740312B (en) | 2013-12-25 | 2013-12-25 | A kind of Chinese medicine composition and its preparation and detection method for being used to treat chronic gastritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310739244.7A CN104740312B (en) | 2013-12-25 | 2013-12-25 | A kind of Chinese medicine composition and its preparation and detection method for being used to treat chronic gastritis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104740312A true CN104740312A (en) | 2015-07-01 |
| CN104740312B CN104740312B (en) | 2018-04-10 |
Family
ID=53580932
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310739244.7A Active CN104740312B (en) | 2013-12-25 | 2013-12-25 | A kind of Chinese medicine composition and its preparation and detection method for being used to treat chronic gastritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104740312B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107505427A (en) * | 2017-08-22 | 2017-12-22 | 成都维恒医药科技有限公司 | A kind of thin-layered chromatography detection method of Chinese medicine sorrel |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080241283A1 (en) * | 2007-03-29 | 2008-10-02 | China Medical University | Aqueous extracts of anoectochilus spp. kinsenoside-comprising pharmaceutical compositions useful for hepatoprotection and uses of the same |
-
2013
- 2013-12-25 CN CN201310739244.7A patent/CN104740312B/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080241283A1 (en) * | 2007-03-29 | 2008-10-02 | China Medical University | Aqueous extracts of anoectochilus spp. kinsenoside-comprising pharmaceutical compositions useful for hepatoprotection and uses of the same |
Non-Patent Citations (3)
| Title |
|---|
| 彭腾等: "白术茯苓汤不同提取方法对脾虚大鼠血管活性肠肽的影响", 《时珍国医国药》 * |
| 李津明: "《现代制药技术》", 30 April 2005, 中国医药科技出版社 * |
| 高华: "《最新国家药品标准实施手册 第3卷》", 31 March 2004, 社会科学文献出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107505427A (en) * | 2017-08-22 | 2017-12-22 | 成都维恒医药科技有限公司 | A kind of thin-layered chromatography detection method of Chinese medicine sorrel |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104740312B (en) | 2018-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103099959B (en) | Traditional Chinese medicine preparation for treating ulcerative colitis and preparation method thereof | |
| CN105343625A (en) | Taraxacum oral liquid for expelling toxin, dehumidifying and benefiting gallbladder and preparation method thereof | |
| CN102988656A (en) | Traditional Chinese medicine composition for treating acute pancreatitis | |
| CN103656377B (en) | A kind of Chinese medicine of internal and external application chronic prostatitis | |
| CN104173950A (en) | Chinese herbal medicine composition for treating prostatic cancer | |
| CN104623376B (en) | Be used for the treatment of prosopalgic medicine | |
| CN104547961B (en) | A kind of Chinese medicine composition for treating gall stone | |
| CN103690791B (en) | A kind of Chinese medicine composition and preparation and determination methods method thereof being used for the treatment of chronic gastritis | |
| CN105412697A (en) | Herba eupatorii oral liquid for clearing heat and removing dampness, and protecting liver and gallbladder and preparation method of oral liquid | |
| CN104721256A (en) | Anwei Yang extract as well as preparation method and medical application thereof | |
| CN104740312A (en) | Traditional Chinese medicine composition for treating chronic gastritis and its preparation method and detection method | |
| CN104547902A (en) | Application of traditional Chinese preparation in preparation of drugs used for treating chronic enteritis and appendicitis | |
| CN104027430A (en) | Traditional Chinese medicine composition for treating blood stasis type uterine myoma | |
| CN110433271A (en) | A kind of pharmaceutical composition and its preparation method and application for treating functional dyspepsia FD | |
| CN103656222B (en) | A kind of Chinese medicine preparation for the treatment of chronic gastritis and preparation method thereof | |
| CN104740313B (en) | One kind treats chronic gastritis Chinese medicine composition and preparation method thereof | |
| CN102114211A (en) | Chinese herbal medicine for treating hepatopathy | |
| CN106963916A (en) | Softing liver and contracting spleen decocts tea | |
| CN105031552A (en) | Traditional Chinese medicine composition for treating gynecological tumors | |
| CN105687362A (en) | Blood-activating dysentery-relieving pill for treating chronic dysentery | |
| CN104940431A (en) | Ligusticum wallichii tea modulating agent | |
| CN104606427A (en) | Schefflera arboricola-contained traditional Chinese medicinal composition | |
| CN104606377A (en) | Traditional Chinese medicinal composition for treating gastritis | |
| CN104587122A (en) | Traditional Chinese medicine composition for treating chronic gastritis | |
| KR20240102982A (en) | Traditional Chinese herbal medicine for the treatment of hives, eczema, allergies/kinetic reactive constitution |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |